메뉴 건너뛰기




Volumn 27, Issue 9, 2007, Pages 633-645

Cost-effectiveness analysis of ziprasidone versus haloperidol in sequential intramuscular/oral treatment of exacerbation of schizophrenia: Economic subanalysis of the ZIMO trial

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; HALOPERIDOL; HYPNOTIC AGENT; NEUROLEPTIC AGENT; SEDATIVE AGENT; ZIPRASIDONE;

EID: 34548102698     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200727090-00005     Document Type: Article
Times cited : (4)

References (47)
  • 1
    • 2942648152 scopus 로고    scopus 로고
    • Schizophrenia
    • Muesler KT, McGurk SR. Schizophrenia. Lancet 2004; 363 (9426): 2063-72
    • (2004) Lancet , vol.363 , Issue.9426 , pp. 2063-2072
    • Muesler, K.T.1    McGurk, S.R.2
  • 2
    • 0344690103 scopus 로고    scopus 로고
    • Multiple-informant rank ing of the disabling effects of different health conditions in 14 countries. WHO/NIH Joint Project CAR Study Group
    • Ustun TB, Rehm J, Chatterji S, et al. Multiple-informant rank ing of the disabling effects of different health conditions in 14 countries. WHO/NIH Joint Project CAR Study Group. Lancet 1999; 354 (9173): 111-5
    • (1999) Lancet , vol.354 , Issue.9173 , pp. 111-115
    • Ustun, T.B.1    Rehm, J.2    Chatterji, S.3
  • 3
    • 0025978419 scopus 로고
    • National Institute of Mental Health longitudinal study of chronic schizophrenia: Prognosis and predictors of outcome
    • Breier A, Schreiber JL, Dyer J, et al. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 1991; 48: 239-46
    • (1991) Arch Gen Psychiatry , vol.48 , pp. 239-246
    • Breier, A.1    Schreiber, J.L.2    Dyer, J.3
  • 4
    • 0034058626 scopus 로고    scopus 로고
    • Prevalencia e incidencia de la esquizofrenia en Navarra
    • Mata I, Beperet M, Madoz V, et al. Prevalencia e incidencia de la esquizofrenia en Navarra. Anales Sis San Navarra 2000; 23 Suppl. 1: 29-36
    • (2000) Anales Sis San Navarra , vol.23 , Issue.SUPPL. 1 , pp. 29-36
    • Mata, I.1    Beperet, M.2    Madoz, V.3
  • 5
    • 0142244688 scopus 로고    scopus 로고
    • Schizophrenia
    • Freedman R. Schizophrenia. N Engl J Med 2003; 349 (18): 1738-49
    • (2003) N Engl J Med , vol.349 , Issue.18 , pp. 1738-1749
    • Freedman, R.1
  • 6
    • 70450000957 scopus 로고    scopus 로고
    • Evolución de la incidencia administrativa de esquizofrenia en Asturias (1987-1997)
    • Iglesia C. Evolución de la incidencia administrativa de esquizofrenia en Asturias (1987-1997). An Psiquiatría 2001; 17 (3): 87-93
    • (2001) An Psiquiatría , vol.17 , Issue.3 , pp. 87-93
    • Iglesia, C.1
  • 7
    • 34548061364 scopus 로고    scopus 로고
    • National Institute of Mental Health:, online, Available from URL:, Accessed Aug 23
    • National Institute of Mental Health: Shizofrenia [online]. Available from URL: http://www.nimh.nih.gov/healthinformation/schizophreniamenu.cfm [Accessed 2006 Aug 23]
    • (2006) Shizofrenia
  • 8
    • 34548094719 scopus 로고    scopus 로고
    • Esquizofrenia: La ficción se convierte en realidad
    • López JM. Esquizofrenia: la ficción se convierte en realidad. Rev Esp Econ Salud 2004; 3 (3): 165-7
    • (2004) Rev Esp Econ Salud , vol.3 , Issue.3 , pp. 165-167
    • López, J.M.1
  • 9
    • 0035121817 scopus 로고    scopus 로고
    • Intramuscular ziprasidone, 2mg versus 10mg, in the short-term management of agitated psychotic patients
    • Lesem MD, Zajecka JM, Swift RH, et al. Intramuscular ziprasidone, 2mg versus 10mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry 2001; 62: 12-8
    • (2001) J Clin Psychiatry , vol.62 , pp. 12-18
    • Lesem, M.D.1    Zajecka, J.M.2    Swift, R.H.3
  • 10
    • 24944456746 scopus 로고    scopus 로고
    • Patient outcomes in schizophrenia. I: Correlates with sociodemographic variables, psychopathology, and side effects
    • Hofer A, Baumgartner S, Edlinger M, et al. Patient outcomes in schizophrenia. I: Correlates with sociodemographic variables, psychopathology, and side effects. Eur Psychiatry 2005; 20 (5-6): 386-94
    • (2005) Eur Psychiatry , vol.20 , Issue.5-6 , pp. 386-394
    • Hofer, A.1    Baumgartner, S.2    Edlinger, M.3
  • 11
    • 0033522368 scopus 로고    scopus 로고
    • Social functioning and neurocognitive deficits in outpatients with schizophrenia: A 2-year follow-up
    • Dickerson F, Boronow JJ, Ringel N, et al. Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up. Schizophr Res 1999; 37 (1): 13-20
    • (1999) Schizophr Res , vol.37 , Issue.1 , pp. 13-20
    • Dickerson, F.1    Boronow, J.J.2    Ringel, N.3
  • 12
    • 0034122979 scopus 로고    scopus 로고
    • Relationship of cognitive functioning, adaptive life skills, and negative symptom severity in poor-outcome geriatric schizophrenia patients
    • McGurk SR, Moriarty PJ, Harvey PD, et al. Relationship of cognitive functioning, adaptive life skills, and negative symptom severity in poor-outcome geriatric schizophrenia patients. J Neuropsychiatry Clin Neurosci 2000; 12 (2): 257-64
    • (2000) J Neuropsychiatry Clin Neurosci , vol.12 , Issue.2 , pp. 257-264
    • McGurk, S.R.1    Moriarty, P.J.2    Harvey, P.D.3
  • 13
    • 0027357587 scopus 로고
    • Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia
    • Addington J, Addington D. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. J Psychiatry Neurosci 1993; 18 (1): 18-23
    • (1993) J Psychiatry Neurosci , vol.18 , Issue.1 , pp. 18-23
    • Addington, J.1    Addington, D.2
  • 14
    • 14844307636 scopus 로고    scopus 로고
    • Rapid-acting IM ziprasidone in a psychiatric emergency service: A naturalistic study
    • Preval H, Klotz SG, Southard R, et al. Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study. Gen Hosp Psychiatry 2005; 27: 140-4
    • (2005) Gen Hosp Psychiatry , vol.27 , pp. 140-144
    • Preval, H.1    Klotz, S.G.2    Southard, R.3
  • 15
    • 33644873400 scopus 로고    scopus 로고
    • Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis
    • CD003079
    • Gillies D, Beck A, McCloud A, et al. Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis. Cochrane Database Syst Rev 2005; (4): CD003079
    • (2005) Cochrane Database Syst Rev , Issue.4
    • Gillies, D.1    Beck, A.2    McCloud, A.3
  • 16
    • 0036724395 scopus 로고    scopus 로고
    • Comprehensive understanding of schizophrenia and its treatment
    • Maguire GA. Comprehensive understanding of schizophrenia and its treatment. Am J Health Syst Pharm 2002; 59 (17 Suppl. 5): S4-11
    • (2002) Am J Health Syst Pharm , vol.59 , Issue.17 SUPPL. 5
    • Maguire, G.A.1
  • 17
    • 0036254886 scopus 로고    scopus 로고
    • Pharmacological treatment of psychotic agitation
    • Currier GW, Trenton A. Pharmacological treatment of psychotic agitation. CNS Drugs 2002; 16 (4): 219-28
    • (2002) CNS Drugs , vol.16 , Issue.4 , pp. 219-228
    • Currier, G.W.1    Trenton, A.2
  • 18
    • 34548065828 scopus 로고    scopus 로고
    • Expert Consensus Guideline Series. Treatment of schizophrenia. J Clin Psychiatry 1999; 60: 1-80
    • Expert Consensus Guideline Series. Treatment of schizophrenia. J Clin Psychiatry 1999; 60: 1-80
  • 19
    • 0031969659 scopus 로고    scopus 로고
    • Current concepts in the pharmacotherapy of acute psychosis
    • Remington GJ, Bezchlibnyk-Butler K. Current concepts in the pharmacotherapy of acute psychosis. CNS Drugs 1998; 9: 191-202
    • (1998) CNS Drugs , vol.9 , pp. 191-202
    • Remington, G.J.1    Bezchlibnyk-Butler, K.2
  • 20
    • 0035902983 scopus 로고    scopus 로고
    • Ziprasidone: A novel antipsychotic agent with a unique human receptor binding profile
    • Schmidt AW, Lebel LA, Howard HR, et al. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 2001; 425: 197-201
    • (2001) Eur J Pharmacol , vol.425 , pp. 197-201
    • Schmidt, A.W.1    Lebel, L.A.2    Howard, H.R.3
  • 21
    • 0034531178 scopus 로고    scopus 로고
    • Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone IM Study Group
    • Brook S, Lucey JV, Gunn KP. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone IM Study Group. J Clin Psychiatry 2000; 61 (12): 933-41
    • (2000) J Clin Psychiatry , vol.61 , Issue.12 , pp. 933-941
    • Brook, S.1    Lucey, J.V.2    Gunn, K.P.3
  • 22
    • 4644245162 scopus 로고    scopus 로고
    • The utility of intramuscular ziprasidone in the management of acute psychotic agitation
    • Mendelowitz AJ. The utility of intramuscular ziprasidone in the management of acute psychotic agitation. Ann Clin Psych 2004; 3 (16): 145-54
    • (2004) Ann Clin Psych , vol.3 , Issue.16 , pp. 145-154
    • Mendelowitz, A.J.1
  • 23
    • 1342264802 scopus 로고    scopus 로고
    • Intramuscular ziprasidone: Moving beyond the conventional in the treatment of acute agitation in schizophrenia
    • Brook S. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia. J Clin Psychiatry 2003; 64 Suppl. 19: 13-8
    • (2003) J Clin Psychiatry , vol.64 , Issue.SUPPL. 19 , pp. 13-18
    • Brook, S.1
  • 24
    • 16844384068 scopus 로고    scopus 로고
    • Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: Comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study
    • Brook S, Walden J, Benattia I, et al. Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study. Psychopharmacology 2005; 78 (4): 514-23
    • (2005) Psychopharmacology , vol.78 , Issue.4 , pp. 514-523
    • Brook, S.1    Walden, J.2    Benattia, I.3
  • 25
    • 34548068138 scopus 로고    scopus 로고
    • ZIMO trial: Effectiveness and tolerability of ziprasidone vs. haloperidol in sequential IM/oral treatment [abstract 146]
    • Pérez V, Gutiérrez-Fraile M, Gutiérrez-casares JR, et al. ZIMO trial: effectiveness and tolerability of ziprasidone vs. haloperidol in sequential IM/oral treatment [abstract 146]. Schizophrenia Research 2006; 81: 93-4
    • (2006) Schizophrenia Research , vol.81 , pp. 93-94
    • Pérez, V.1    Gutiérrez-Fraile, M.2    Gutiérrez-casares, J.R.3
  • 26
    • 0029816392 scopus 로고    scopus 로고
    • Quality of life in schizophrenia: Relationship to sociodemographic factors, symptomatology and tardive dyskinesia
    • Browne S, Roe M, Lane A, et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 1996; 94: 118-24
    • (1996) Acta Psychiatr Scand , vol.94 , pp. 118-124
    • Browne, S.1    Roe, M.2    Lane, A.3
  • 27
    • 0032696451 scopus 로고    scopus 로고
    • Family attributions and coping in the prediction of emotional adjustment in family members of patients with first-episode schizophrenia
    • Hinrichsen GA, Lieberman JA. Family attributions and coping in the prediction of emotional adjustment in family members of patients with first-episode schizophrenia. Acta Psychiatr Scand 1999; 100 (5): 359-66
    • (1999) Acta Psychiatr Scand , vol.100 , Issue.5 , pp. 359-366
    • Hinrichsen, G.A.1    Lieberman, J.A.2
  • 28
    • 5744246783 scopus 로고    scopus 로고
    • Length of stay and antipsychotic treatment costs of patients with acute psychosis admitted to hospital in Spain: Description and associated factors. The Psychosp study
    • Peiro S, Gómez G, Guadarrama I, et al. Length of stay and antipsychotic treatment costs of patients with acute psychosis admitted to hospital in Spain: description and associated factors. The Psychosp study. Soc Psychiatry Psychiatr Epidemiol 2004; 39 (7): 507-13
    • (2004) Soc Psychiatry Psychiatr Epidemiol , vol.39 , Issue.7 , pp. 507-513
    • Peiro, S.1    Gómez, G.2    Guadarrama, I.3
  • 29
    • 34548091415 scopus 로고    scopus 로고
    • Catalogo de Especialidades Farmacéuticas 2005. Consejo General de Colegios Oficiales de Farmacéuticos, Madrid 2005
    • Catalogo de Especialidades Farmacéuticas 2005. Consejo General de Colegios Oficiales de Farmacéuticos, Madrid 2005
  • 31
    • 7844224760 scopus 로고    scopus 로고
    • Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 4-week placebo-controlled trial
    • Keck P, Buffenstein A, Ferguson F, et al. Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial. Psychopharmacol 1998; 140: 173-84
    • (1998) Psychopharmacol , vol.140 , pp. 173-184
    • Keck, P.1    Buffenstein, A.2    Ferguson, F.3
  • 32
    • 0030920294 scopus 로고    scopus 로고
    • Quetiapine in patients with schizophrenia: A high- and low-dose comparison with placebo
    • Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia: a high- and low-dose comparison with placebo. Arch Gen Psych 1997; 54: 549-57
    • (1997) Arch Gen Psych , vol.54 , pp. 549-557
    • Small, J.G.1    Hirsch, S.R.2    Arvanitis, L.A.3
  • 33
    • 0030795988 scopus 로고    scopus 로고
    • Seroquel Trial 13 Study Group. Multiple fixed doses of Seroquel (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
    • Arvanitis LA, Millar BG, Seroquel Trial 13 Study Group. Multiple fixed doses of Seroquel (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biological Psychiatry 1997; 42: 233-46
    • (1997) Biological Psychiatry , vol.42 , pp. 233-246
    • Arvanitis, L.A.1    Millar, B.G.2
  • 34
    • 0030805337 scopus 로고    scopus 로고
    • A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia
    • Peuskens J, Link CGG. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. Acta Psychiatr Scand 1997; 96: 265-73
    • (1997) Acta Psychiatr Scand , vol.96 , pp. 265-273
    • Peuskens, J.1    Link, C.G.G.2
  • 36
    • 0032770123 scopus 로고    scopus 로고
    • The economic burden of schizophrenia in Canada
    • Goeree R, O'Brien BJ, Goering P, et al. The economic burden of schizophrenia in Canada. Can J Psychiatry 1999; 44 (5): 464-72
    • (1999) Can J Psychiatry , vol.44 , Issue.5 , pp. 464-472
    • Goeree, R.1    O'Brien, B.J.2    Goering, P.3
  • 37
    • 26644472427 scopus 로고    scopus 로고
    • The economic burden of schizophrenia in the United States in 2002
    • Wu EQ, Birnbaum HG, Shi L, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry 2005; 66 (9): 1122-9
    • (2005) J Clin Psychiatry , vol.66 , Issue.9 , pp. 1122-1129
    • Wu, E.Q.1    Birnbaum, H.G.2    Shi, L.3
  • 38
    • 0043146959 scopus 로고    scopus 로고
    • Symptom effects on employment in a structural model of mental illness and treatment: Analysis of patients with schizophrenia
    • Slade E, Salkever D. Symptom effects on employment in a structural model of mental illness and treatment: analysis of patients with schizophrenia. J Ment Health Policy Econ 2001; 4 (1): 25-34
    • (2001) J Ment Health Policy Econ , vol.4 , Issue.1 , pp. 25-34
    • Slade, E.1    Salkever, D.2
  • 39
    • 0034101231 scopus 로고    scopus 로고
    • Necesidades sociales de los enfermos esquizofrénicos en Navarra
    • Abaurrea P, Astrain MV, Elgoriaga G, et al. Necesidades sociales de los enfermos esquizofrénicos en Navarra. Anales Sis San Navarra 2000; 23 Suppl. 1: 95-9
    • (2000) Anales Sis San Navarra , vol.23 , Issue.SUPPL. 1 , pp. 95-99
    • Abaurrea, P.1    Astrain, M.V.2    Elgoriaga, G.3
  • 40
    • 0028083282 scopus 로고
    • Needs of family caregivers in chronic schizophrenia
    • Winefield HR, Harvey EJ. Needs of family caregivers in chronic schizophrenia. Schizophr Bull 1994; 20 (3): 557-66
    • (1994) Schizophr Bull , vol.20 , Issue.3 , pp. 557-566
    • Winefield, H.R.1    Harvey, E.J.2
  • 41
    • 33644768462 scopus 로고    scopus 로고
    • Family burden and social network in schizophrenia vs. physical diseases: Preliminary results from an Italian national study
    • Magliano L, Fiorillo A, Rosa C, et al. Family burden and social network in schizophrenia vs. physical diseases: preliminary results from an Italian national study. Acta Psychiatr Scand 2006; 429 Suppl.: 60-3
    • (2006) Acta Psychiatr Scand , vol.429 , Issue.SUPPL. , pp. 60-63
    • Magliano, L.1    Fiorillo, A.2    Rosa, C.3
  • 42
    • 0031025299 scopus 로고    scopus 로고
    • Psychosocial dimensions of family burden among two groups of carers looking after psychiatric patients
    • Bibou-Nakou I, Dikaiou M, Bairactaris C. Psychosocial dimensions of family burden among two groups of carers looking after psychiatric patients. Soc Psych Psychiatric Epidemiol 1997; 32: 104-8
    • (1997) Soc Psych Psychiatric Epidemiol , vol.32 , pp. 104-108
    • Bibou-Nakou, I.1    Dikaiou, M.2    Bairactaris, C.3
  • 43
    • 0032696451 scopus 로고    scopus 로고
    • Family attributions and coping in the prediction of emotional adjustment in family members of patients with first-episode schizophrenia
    • Hinrichsen GA, Lieberman JA. Family attributions and coping in the prediction of emotional adjustment in family members of patients with first-episode schizophrenia. Acta Psych Scand 1999; 100: 359-66
    • (1999) Acta Psych Scand , vol.100 , pp. 359-366
    • Hinrichsen, G.A.1    Lieberman, J.A.2
  • 44
    • 0031863868 scopus 로고    scopus 로고
    • Expressed emotion, attributions, and schizophrenia symptom dimensions
    • Weisman AG, Nuechterlein KH, Goldstein MJ, et al. Expressed emotion, attributions, and schizophrenia symptom dimensions. J Abnorm Psychol 1998; 107: 355-9
    • (1998) J Abnorm Psychol , vol.107 , pp. 355-359
    • Weisman, A.G.1    Nuechterlein, K.H.2    Goldstein, M.J.3
  • 45
    • 14644393062 scopus 로고    scopus 로고
    • Brady N, McCain G. Living with schizophrenia: a family perspective. Online Journal of Issues in Nursing 2004 Nov; 10 (1) [online]. Available from URL: http://nursingworld.org/ojin/hirsh/topic4/tpc4_2.htm [Accessed 2006 Aug 29]
    • Brady N, McCain G. Living with schizophrenia: a family perspective. Online Journal of Issues in Nursing 2004 Nov; 10 (1) [online]. Available from URL: http://nursingworld.org/ojin/hirsh/topic4/tpc4_2.htm [Accessed 2006 Aug 29]
  • 46
    • 0034013706 scopus 로고    scopus 로고
    • Sobrecarga de los cuidadores familiares de pacientes con esquizofrenia: Factores determinantes
    • Martínez A, Nadal S, Beperet M, et al. Sobrecarga de los cuidadores familiares de pacientes con esquizofrenia: factores determinantes. Anales Sis San Navarra 2000; 23 Suppl. 1: 101-10
    • (2000) Anales Sis San Navarra , vol.23 , Issue.SUPPL. 1 , pp. 101-110
    • Martínez, A.1    Nadal, S.2    Beperet, M.3
  • 47
    • 34548086342 scopus 로고    scopus 로고
    • Instituto Nacional de Estadística, online, Available from URL:, Accessed Oct 2
    • Instituto Nacional de Estadística. Encuesta trimestral de coste laboral [online]. Available from URL: http://www.ine.es/daco/daco42/etcl/ etcl0405.pdf [Accessed 2006 Oct 2]
    • (2006) Encuesta trimestral de coste laboral


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.